Muhlenkamp Co Inc Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Muhlenkamp Co Inc reduced its stake in UnitedHealth Group Inc by 0.43% during the most recent quarter end. The investment management company now holds a total of 60,220 shares of UnitedHealth Group Inc which is valued at $8,559,069 after selling 260 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.UnitedHealth Group Inc makes up approximately 3.21% of Muhlenkamp Co Inc’s portfolio.

Other Hedge Funds, Including , Vestor Capital reduced its stake in UNH by selling 20,090 shares or 23.31% in the most recent quarter. The Hedge Fund company now holds 66,094 shares of UNH which is valued at $9,393,940. UnitedHealth Group Inc makes up approx 2.57% of Vestor Capital’s portfolio.Coho Partners Ltd. boosted its stake in UNH in the latest quarter, The investment management firm added 66,095 additional shares and now holds a total of 783,954 shares of UnitedHealth Group Inc which is valued at $112,097,582. UnitedHealth Group Inc makes up approx 3.97% of Coho Partners Ltd.’s portfolio.Deltec Asset Management reduced its stake in UNH by selling 50 shares or 0.1% in the most recent quarter. The Hedge Fund company now holds 47,650 shares of UNH which is valued at $6,751,052. UnitedHealth Group Inc makes up approx 1.62% of Deltec Asset Management’s portfolio.Concorde Asset Management reduced its stake in UNH by selling 153 shares or 4.97% in the most recent quarter. The Hedge Fund company now holds 2,928 shares of UNH which is valued at $420,724. UnitedHealth Group Inc makes up approx 0.41% of Concorde Asset Management’s portfolio.

UnitedHealth Group Inc opened for trading at $141.29 and hit $141.91 on the upside on Wednesday, eventually ending the session at $141.71, with a gain of 0.45% or 0.63 points. The heightened volatility saw the trading volume jump to 18,49,066 shares. Company has a market cap of $134,963 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Investors should note that on Aug 3, 2016, UnitedHealth Group Inc announced a cash dividend of $0.6250. The company’s management has announced Sep 7, 2016 as the ex-dividend date and fixed the record date on Sep 9, 2016. The payable date has been fixed on Sep 20, 2016.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.